GLOBUS MEDICAL INC insider trading

GMEDNYSE

$75.60+1.19 (+1.60%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+30.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Unlock quarterly net flow

Key players

DDDavid D. DavidarDirector0.5017%of company
DCDavid C. PaulExecutive Chairman0.045%of company
ADAnn D. RhoadsDirector0.0301%of company
LVLeslie V. NorwalkDirector0.0078%of company
JRJames R. TobinDirector0.00%of company
STStephen T. ZarrilliDirector0.00%of company
KWKeith W. PfeilPresident, CEO0.00%of company
KKKyle KlineSenior Vice President, CFO0.00%of company
DTDaniel T. ScavillaPresident, CEO0.00%of company
KHKelly HullerEVP, GC, Corporate Secretary0.00%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
GMED	Leslie V. NorwalkDirector	Open market sell$202K	-16.1%	$101.10	$202K	Jan 8, 2026	Jan 12, 2026
GMED	Leslie V. NorwalkDirector	Open market sell$355K	-24.4%	$88.85	$355K	Dec 12, 2025	Dec 16, 2025
GMED	Ann D. RhoadsDirector	Open market sell$170K	-11.5%	$85.00	$170K	Nov 10, 2025	Nov 10, 2025
GMED	Ann D. RhoadsDirector	Open market sell$648K	-31.5%	$81.00	$648K	Nov 7, 2025	Nov 10, 2025

End of history · 4 transactions